Knockdown of CABYR-a/b significantly inhibits proliferation of lung cancer cells, attenuates Akt phosphorylation, decreases phosphorylated GSK levels, and increases the levels of p53 and p27 proteins (53). Here, TP53 is linked to lung cancer.